https://www.businessline.global/takeda-announces-approval-of-takhzyro-lanadelumab-subcutaneous-injection-in-china-for-the-treatment-of-hereditary-angioedema/press-release/
Takeda Announces Approval of TAKHZYRO® (lanadelumab) subcutaneous injection in China for the Treatment of Hereditary Angioedema